Pancreatic Neoplasms: all 3,311 studies
Page 16 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic CancerActive, not recruitingNCT06090916Not applicable
- Quality of Life in Elderly Patients After Pancreatic Cancer SurgeryCompletedNCT06079229
- Role of Pre-operative CPET in PancreatoduodenectomyCompletedNCT06068452
- Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsTerminatedNCT06065059Phase 1/2
- Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDACActive, not recruitingNCT06059001Phase 1
- TCR-T Cells in the Treatment of Advanced Pancreatic CancerStatus unknownNCT06054984Early Phase 1
- Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility StudyWithdrawnNCT06054308Not applicable
- The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment ResponseCompletedNCT06050395Not applicable
- Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or ReconstructionCompletedNCT06024343Not applicable
- Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal AdenocarcinomaWithdrawnNCT06017323Phase 1
- ZN-c3 + Gemcitabine in Pancreatic CancerActive, not recruitingNCT06015659Phase 2
- Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)Active, not recruitingNCT06001268Not applicable
- A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic CancerActive, not recruitingNCT05984602Phase 1
- A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.TerminatedNCT05977322Phase 1
- First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer PatientsCompletedNCT05964361Phase 1/2
- Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.CompletedNCT05959213
- A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7SuspendedNCT05958199Phase 1
- Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsActive, not recruitingNCT05945823Phase 2
- Province of Ontario Strategy for Personalized Management of Pancreatic Cancer TrialActive, not recruitingNCT05927298
- Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy EfficacyActive, not recruitingNCT05927142Phase 1/2
- Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin AmericaCompletedNCT05924789
- Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic CancerActive, not recruitingNCT05922930Phase 1/2
- Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)Active, not recruitingNCT05915351Phase 2
- Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic CancerTerminatedNCT05911243Not applicable
- Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic CancerCompletedNCT05908747Phase 2
- A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsActive, not recruitingNCT05907304Phase 1
- Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic PancreatitisCompletedNCT05906615Phase 2
- Percutaneous Holmium Injection in Pancreatic CancerActive, not recruitingNCT05880472Not applicable
- 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic CancerStatus unknownNCT05875753Early Phase 1
- A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsCompletedNCT05864144Phase 1/2
- GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic CancerWithdrawnNCT05861336Phase 2
- Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic CancerTerminatedNCT05841706Early Phase 1
- Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic CancerCompletedNCT05840341Phase 3
- Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic CancerActive, not recruitingNCT05836870Phase 3
- Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post SurgeryStatus unknownNCT05830019Not applicable
- Proglumide and Chemotherapy for Metastatic Pancreatic CancerActive, not recruitingNCT05827055Phase 2
- The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic CancerStatus unknownNCT05802420Not applicable
- Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic CancerCompletedNCT05745415
- PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9WithdrawnNCT05737615Phase 1
- A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 ExpressionActive, not recruitingNCT05736731Phase 1/2
- Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant TreatmentCompletedNCT05722223Not applicable
- Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic CancerCompletedNCT05721846Phase 1
- Risk Factors for Postoperative Pancreatic Fistula Following Non-traumatic Pancreatic Surgery. Retrospective Observational Study.CompletedNCT05711433
- The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After PancreatoduodenectomyCompletedNCT05709197Not applicable
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)CompletedNCT05708950Phase 1/2
- Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsActive, not recruitingNCT05704985Phase 1
- Clinical Utility Study for Exo-PDACWithdrawnNCT05702385Not applicable
- Porto-Venous Radiomics in Pancreatic CancerStatus unknownNCT05700110
- Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic CancerStatus unknownNCT05689138
- Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority PopulationsActive, not recruitingNCT05687188
- CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic CancerSuspendedNCT05685602Phase 1
- Expanded Access RBS2418 TreatmentNo longer availableNCT05683470
- The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer PatientsCompletedNCT05680870Phase 3
- Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionActive, not recruitingNCT05677048Not applicable
- Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer PatientsCompletedNCT05675059Not applicable
- Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerActive, not recruitingNCT05669482Phase 1/2
- Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes AlterationsActive, not recruitingNCT05659914Phase 2
- Radiomics in Pancreatic CancerStatus unknownNCT05658679
- A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic CancerTerminatedNCT05657418Phase 1
- Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Active, not recruitingNCT05642962Phase 1/2
- Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After PancreatoduodenectomyStatus unknownNCT05641233Phase 1/2
- Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic CancerActive, not recruitingNCT05638698Phase 2
- Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic CancerStatus unknownNCT05634564Phase 2
- Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer PatientsWithdrawnNCT05634525Phase 1
- AGEN1423 and Botensilimab w/ or w/o Chemo in PDACActive, not recruitingNCT05632328Phase 2
- Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerTerminatedNCT05631574Phase 1
- Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard ChemotherapyStatus unknownNCT05627427Phase 2
- Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic UltrasoundCompletedNCT05617872Not applicable
- Textbook Outcome as a Composite Outcome Measure in Laparoscopic PancreaticoduodenectomyCompletedNCT05616403
- Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /PlaceboStatus unknownNCT05613465Not applicable
- Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the LiverWithdrawnNCT05610826Phase 1/2
- DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic CancerStatus unknownNCT05604573
- Early Detection of Pancreatic CancerStatus unknownNCT05596435
- Pancreatic and Periampullary Tumors in Greenland InuitCompletedNCT05595811
- Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical ResectionCompletedNCT05589480
- Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of KoreaStatus unknownNCT05587387
- Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)Status unknownNCT05587088Phase 1/2
- A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic CancerCompletedNCT05586516Phase 1/2
- A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals.CompletedNCT05583890
- A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With ChemotherapyCompletedNCT05573776Not applicable
- Establishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy SamplesStatus unknownNCT05571956Not applicable
- A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid TumorsTerminatedNCT05571839Phase 1
- A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer PancreasStatus unknownNCT05566743Phase 2
- Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialActive, not recruitingNCT05554367Phase 2
- Efficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno-pancreatectomyCompletedNCT05546970
- Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaActive, not recruitingNCT05539430Phase 1
- Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid TumorsCompletedNCT05538195Phase 1/2
- Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic CancerCompletedNCT05535894
- Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.CompletedNCT05528614
- Pancreatic Cancer Early Detection RegistryCompletedNCT05519930
- PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic CancerTerminatedNCT05518110Phase 2
- Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and BorderlineCompletedNCT05514171
- Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRIStatus unknownNCT05511116
- A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.Active, not recruitingNCT05497778Phase 1
- Home-based Prehabilitation in Pancreatic ResectionCompletedNCT05496777Not applicable
- iDentification and vAlidation Model of Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for Pancreatic Cancer (DAYBREAK Study)Status unknownNCT05495685
- A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT05494866Phase 1
- Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPCSuspendedNCT05494697Phase 2
- A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.CompletedNCT05493995Phase 2
- ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract CancerStatus unknownNCT05493878